HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer's Upjohn Breaking The Silence Around ED With New Viagra Connect Campaign In UK

Executive Summary

Pfizer is investing roughly $10m in Viagra Connect in the UK to help raise awareness of erectile problems among the country's male population. 

You may also be interested in...



Viatris Offers Viagra Connect In Smaller Trial Pack For UK Men

Viartris hopes its Viagra Connect two-pack will encourage British men to seek treatment for erectile dysfunction. 

Dutch Firm TheOTCLabs Enters UK Market With Kidsner Range

Amsterdam-based TheOTCLabs breaks into the UK consumer health market with Kidsner, a playfully marketed range of wellness products aimed at children aged 4 to 12 years old. 

UK Health Service Not Taking Full Advantage Of Digital Self-Care Apps – PAGB Audit

PAGB calls on NHS England to create a self-care section in its NHS App and reinstate its online Apps Library to promote responsible digital self-care in the UK. 

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150238

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel